HEART FAILURE NYHA CLASS III
Clinical trials for HEART FAILURE NYHA CLASS III explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE NYHA CLASS III trials appear
Sign up with your email to follow new studies for HEART FAILURE NYHA CLASS III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Nerve-Zapping device could cut heart failure deaths
Disease control ENROLLING_BY_INVITATIONThis study tests a device called Barostim that stimulates nerves to help control heart failure. It involves 2500 adults with moderate heart failure who still have symptoms despite standard medications. The goal is to see if the device reduces deaths and heart-related emergencies …
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: CVRx, Inc. • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New implant could help heart failure patients stay out of hospital
Disease control OngoingThis study tests a small sensor implanted in the lung artery to monitor pressure in people with advanced heart failure (NYHA Class III). The goal is to see if the device is safe and accurate, helping doctors adjust treatment early to prevent hospital stays. About 81 adults will r…
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: Endotronix, Inc. • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
Heart failure study tracks metabolic shifts from common drug
Knowledge-focused ENROLLING_BY_INVITATIONThis study watches 40 adults with heart failure to see how SGLT2 inhibitors affect their body's energy use and blood markers. Participants do a walking test, a leg MRI, and give blood samples before and after starting the drug. The goal is to understand the early metabolic change…
Matched conditions: HEART FAILURE NYHA CLASS III
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:01 UTC